Locus 99: ACADS (12q24.31)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2066938 |
butyrylcarnitine |
A/G |
7349 |
0.74 |
-0.211 (0.004) |
3.16·10-630 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs2066938 |
| Chromosomal location | Chr12: 119,644,998 (12q24.31) |
| Gene (distance) | ACADS (-2,955) |
| Predicted causal gene | ACADS |
| Gene/protein classification | - |
| Metabolite (Pathway) | butyrylcarnitine (Fatty acid metabolism (also BCAA metabolism); Lipid) |
| Biochemical locus-metabolite relationship | ACADS encodes the short chain acyl-CoA dehydrogenase which takes butyrl-CoA as a substrate [3597357]. Butyryl-CoA and butyrylcarnitine readily interconvert. Rs2066938 is in strong LD with a missense mutation within ACADS (rs1799958) which decreases the activity and thermal stability of the enzyme [12220177]. |
| eQTL associations | MLEC (F) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | butyrylcarnitine/propionylcarnitine [21886157]; C3/C4 [20037589] |
| Inborn error of metabolism | Short chain acyl-CoA dehydrogenase deficiency. |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

